CD8A and COVID-19: In perspective, the identification of some general and persistent immunological alterations in COVID-19, such as a decrease in naïve CD8+ T cells in the present study and/or others from additional studies, could be used to better assess these patients during the acute phase and/or monitor their longitudinal course (with respect to the potential occurrence of long COVID-19, too).